Related Experiment Video
Updated: Jun 27, 2026

Neurogenesis Using P19 Embryonal Carcinoma Cells
Published on: April 27, 2019
A sequel to the tale of p25/Cdk5 in neurodegeneration
Burcin Ikiz1, Serge Przedborski
1Department of Neurology, Pathology, and Cell Biology and Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
Abstract:
p25/Cdk5 dysregulation may contribute to neurodegeneration. In this issue of Neuron, Kim et al. show that cdk5 inactivates HDAC-1, leading to cell cycle deregulation and DNA damage accumulation. This study provides further insights into the function of p25/Cdk5 in neurons and points to HDAC-1 as a target for therapeutic interventions.
Insights
The p25/Cyclin-dependent kinase 5 (Cdk5) complex inactivates Histone deacetylase 1 (HDAC-1), causing cell cycle errors and DNA damage. This neurotoxic mechanism in neurons highlights HDAC-1 as a potential therapeutic target for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Dysregulation of p25/Cyclin-dependent kinase 5 (Cdk5) is implicated in neurodegenerative processes.
- Understanding the molecular mechanisms linking p25/Cdk5 to neuronal dysfunction is crucial.
Purpose of the Study:
- To elucidate the role of Cdk5 in regulating HDAC-1 activity.
- To investigate the downstream consequences of p25/Cdk5-mediated HDAC-1 inactivation in neurons.
Main Methods:
- Biochemical assays to assess Cdk5 kinase activity.
- Cellular models to study cell cycle regulation and DNA damage.
- Western blotting and immunofluorescence techniques.
Main Results:
- Cdk5 was found to inactivate Histone deacetylase 1 (HDAC-1).
- HDAC-1 inactivation by Cdk5 led to cell cycle deregulation.
- Accumulation of DNA damage was observed in neurons under these conditions.
Conclusions:
- The p25/Cdk5 complex plays a critical role in neuronal cell cycle control through HDAC-1 inhibition.
- This pathway contributes to DNA damage, a hallmark of neurodegeneration.
- HDAC-1 emerges as a potential therapeutic target for neurodegenerative disorders.
Related Concept Videos
Inhibition of Cdk Activity
Neurogenesis and Regeneration of Nervous Tissue
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex

